Table 2 |
||||
|
CPET1 and CPET2 in CSF/ME patients versus controls& |
||||
|
CPET1 |
CPET2 |
|||
|
|
||||
|
Patients n = 15 |
Controls n = 15 |
Patients n = 15 |
Controls n = 15 |
|
|
|
||||
|
FVC (L) |
3.70 ± 0.73 |
3.71 ± 0.77 |
3.71 ± 0.73 |
3.76 ± 0.72 |
|
|
||||
|
FEV 1 (L) |
2.95 ± 0.61 |
2.98 ± 0.55 |
2.94 ± 0.46 |
3.05 ± 0.53 |
|
|
||||
|
Rest |
||||
|
|
||||
|
Heart rate (beats/min) |
86.5 ± 10.6 |
80.7 ± 8.6 |
87.9 ± 11.2 |
80.9 ± 8.8 |
|
|
||||
|
O2 pulse (mL/beat) |
4.43 ± 0.72 |
4.73 ± 0.86 |
4.26 ± 0.76 |
4.73 ± 0.88 |
|
|
||||
|
V'O2/kg [mL/(min.kg)] |
5.93 ± 1.28 |
6.27 ± 0.80 |
5.87 ± 1.30 |
6.20 ± 0.56 |
|
|
||||
|
Anaerobic Threshold |
||||
|
|
||||
|
WR (Watt) |
58.6 ± 24.2 |
82.9 ± 29.1* |
54.5 ± 20.9 |
92.9 ± 31.1** |
|
|
||||
|
Heart rate (beats/min) |
110 ± 14 |
111 ± 10 |
112 ± 13 |
118 ± 10# |
|
|
||||
|
O2 pulse (mL/beat) |
7.69 ± 1.50 |
9.19 ± 2.42 |
7.01 ± 1.74 # |
9.48 ± 2.69** |
|
|
||||
|
V'O2/kg [mL/(min.kg)] |
12.8 ± 3.0 |
16.7 ± 4.0** |
11.9 ± 2.9 |
18.0 ± 4.6**# |
|
|
||||
|
V'E/V'CO2 |
29.2 ± 2.3 |
26.9 ± 1.5** |
29.1 ± 3.7 |
25.7 ± 2.0**# |
|
Maximal exercise |
||||
|
|
||||
|
WR (Watt) |
132 ± 30 |
188 ± 46** |
125 ± 35 |
196 ± 51** ## |
|
|
||||
|
Heart rate (beats/min) |
158 ± 20 |
167 ± 8 |
155 ± 21 |
168 ± 8* |
|
|
||||
|
O2 pulse (mL/beat) |
9.19 ± 2.18 |
12.43 ± 5.25* |
8.82 ± 2.20. |
11.70 ± 3.01** |
|
|
||||
|
V'O2/kg [mL/(min.kg)] |
22.3 ± 5.7 |
31.2 ± 7.0** |
20.9 ± 5.5 ## |
31.9 ± 7.4**# |
|
|
||||
|
& Data are presented as mean ± SD Differences evaluated by multivariate or repeated measures ANOVA: *: P < 0.05; ** P < 0.01 between patients and controls #: P < 0.05; ## P < 0.01 between CPET1 and CPET2 |
||||
|
Vermeulen et al. Journal of Translational Medicine 2010 8:93 doi:10.1186/1479-5876-8-93 |
||||
